There is a huge difference in what you would call red

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps craigakess #105951
511
There is a huge difference in what you would call red flags. Your words were they are learning on the job. I agree that we have learned things as we have gone forward and we are the better for it. You must remember 20/20 hindsight is what they have been judged on. Our management didn’t bash the FDA or any competitor company and only praised both. This shows class and respect which I admire.

Nader May walk the line of speculation but what he tells you he believes and it truly is speculation. Of coarse as a lawyer like you are you know all to well what that disclosure statement at the beginning of every CC or webcast tells you the liability is still there and future speculation is just that…

I don’t believe Nader out right lies to us. I believe he is just the opposite of you in a hopeful optimist. Nader and I share this hopeful optimist. He is terrible at setting timelines and I won’t hate him for it but others do. I don’t take timelines as a matter of fact after he missed his first one. I believe in living and learning who you might listen to and judge what you can gather from that person. Does this person always show up late? Or does this person never make a deadline? These observations won’t continue to upset me when I realize they are not accurate in timelines. The saying come to mind… I take it with a grain of salt. I don’t expect this person to be accurate anymore. I don’t call their lack of making a timeline lying to me as some have.

So the big difference to me is bashing is disrespectful and not acceptable to me especially when they are half truths and out right lies. You don’t build trust with me when you lie at other expense. Then to continue to hammer relentlessly over and over and don’t really even believe what your pushing just to keep a negative campaign going just doesn’t make sense to a optimist. It disgusts me. I would venture to say that most investors hope for Leronlimab are optimistic for Leronlimab. Maybe not a full out optimist like me but a partial gambling investor and believe the science and has done the proper D&D.

My hope is they are not wearing blinders when watching the 13d group present their thinly veiled ideas that lack priorities and proper business sense. They clearly are off base with a future of our company and that is very suspect. So much so that most believe they are here to sell us out for pennies. Now why would we believe that? Maybe no plan or future direction or promises of anything more than a year out. Kind of gives you that warm and fuzzy feeling that you don’t get from this group.

I do receive that feeling from our current management because that was their mission statement at last years stockholders meeting. Do you remember? We will be come our own pharmaceutical company. This is a future to get behind. This is the best case scenario for our investment. But maybe you think it’s worth the risk to be sold to big Pharma and can allow the 13d your votes. Myself… I am smarter than that and have no trust with them. They haven’t earned any and have only lied to me. Hence the trust issue.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 2

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 0

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 0

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 0

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 2

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Gabelli Funds Unveils Seven Fully Transparent ETF Options

Updated Category News Views 87

Introducing Gabelli's Fully Transparent ETF Strategies Gabelli Funds, LLC has embarked on an exciting new chapter by making all of its actively managed exchange-traded funds (ETFs) fully transparent. This progressive move enhances accessibility for both advisors and investors, aligning with the firm’s fundamental investment philosophy of bottom-up research. Gabelli’s...

Continue Reading
Bitcoin Prices Hit New Heights Amidst Market Excitement

Updated Category News Views 77

Bitcoin Reaches New All-Time High Bitcoin, the leading cryptocurrency in the market, has recently surged to a remarkable record high approaching $95,000. This significant price spike follows reports suggesting potential collaborations that may pave the way for a more favorable environment for cryptocurrencies in the financial landscape. Market Reactions and Implications...

Continue Reading
Manpower Achieves Top Position in Industry PEAK Matrix Assessment

Updated Category News Views 78

Manpower Recognized Among Industry Leaders Manpower, a global leader in staffing and workforce solutions, has recently earned a notable accolade by being named a Leader in the Everest Group's 2024 U.S. Contingent Talent and Strategic Solutions PEAK Matrix Assessment. This recognition underscores the company's commitment to excellence and innovation in the staffing...

Continue Reading
Exploring the Growing FIBC Market and Its Future Trends

Updated Category News Views 358

The Rising FIBC Market: An Overview The global Flexible Intermediate Bulk Container (FIBC) market is on a promising growth trajectory, with projections indicating an increase in market valuation from USD 7.4 billion in the near future to an impressive USD 11.5 billion by the year 2035. This growth reflects a compound annual growth rate (CAGR) of 4.5% from now to 2035,...

Continue Reading
Real Matters Q3 Financial Performance: Trends and Insights

Updated Category News Views 117

Real Matters Reports Impressive Q3 Financial Results (All amounts are expressed in millions of U.S. dollars, excluding per share amounts, unless otherwise stated.) TORONTO – Real Matters Inc. (TSX: REAL), a leader in providing network management services for the mortgage and insurance sectors, has announced its financial results for the third quarter, showcasing a...

Continue Reading